Speaker Profile
PMWC PIONEER AWARD
Honored for bringing nanopore long-read sequencing into clinical practice, enabling real-time whole-genome analysis (SVs, phasing, methylation) and faster results from sample to report
Ph.D., CEO and Co-Founder, Oxford Nanopore
Biography
CEO and co-founder of Oxford Nanopore Technologies, pioneering real-time, scalable DNARNA sequencing. With a PhD in bioelectronic technology, he led the company from spinout to global player, transforming genomics with portable sequencing devices. Sanghera champions accessible, decentralized sequencing for research, healthcare, and public health worldwide.
Talk
In conversation with Gordon Sanghera
Gordon will chart his journey as CEO of Oxford Nanopore, from early vision and product development, through to scaling operations, navigating challenges, achieving their IPO and onward growth since then. He reflects on the importance of culture, innovation and resilient leadership, and how these strong foundations can help to drive the company forward.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Mark Daly, Broad Institute (implied from context, but you didn’t restate – leaving just content here as requested)
PMWC Award Ceremony
• Mark Daly, Broad Institute
• Gordon Sanghera, Oxford Nanopore
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley/UCSC
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford
• Barrett Bready, Nabsys
Keynote: Biobanks and the Road Ahead in Human Genetics
• Mark Daly, Broad Institute/FinnGen
AI and Evolution for Predicting Human Disease Genes
• Chair: Yuval Tabach, Hebrew University
• Nilah Ioannidis, UC Berkeley/UCSC
• Sasa Jenko, European Commission
DNA to Drug, Label & Coverage: From Genetic Signals to Approval & Access
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B Altman, Stanford
• Slavé Petrovski, AstraZeneca
• Wei Zhou, Broad Institute
25+ Years of the Human Genome — From Bench to Bedside to Beyond
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health
